Micromet(德国)

Micromet

德国Micromet www.micromet.deMicromet创建于德国，总部现设在马里兰州的Rockville，该公司正在开发一款试验性血癌治疗药物，目前处在中期试验阶段。Micrometwasfoundedin1993byasmallteamofentrepreneurialscientistsfromtheUniversityofMunichwithafirmbeliefinthepo tentialofTcellbasedtherapiestotreatcancer.TheirvisionwastodevelopanewclassofdrugsthatmobilizeTcells,thebody'smostpotentkillercells,enablingthemtodetectanddestroynormallyunrecognizablecancercells.Withinafewshortyears,theCompanydemonstratedtheclinicalpotentialofitstechnology,referredtoasBiTE®(Bi-specificTcellengager),withthepublicationofcompellingresultsfromaPhase1trialofitsBiTEantibodyBlinatumomab(MT103)inpatientswithnon-Hodgkin'slymphoma.MicrometbegantradingontheNasdaqGlobalMarketunderthesymbolMITIfollowingaMay2006reversemergerwithCalifornia-basedCancerVax.TodayMicrometisanintegratedbiopharmaceuticalcompanywitha